INS and familial pancreatic carcinoma: Whereas the availability of comorbid conditions in the VACCR is a major strength of our study and permitted this analysis, various aspects of DM history such as duration, occurrence after pancreatic cancer diagnosis, and type of DM treatments (biguanides, sulfonylureas, insulin etc) were not known.